Skip to main content
. 2021 Jan 20;88(4):828–837. doi: 10.1093/neuros/nyaa544

TABLE 3.

Imaging Follow-up

Characteristic
Available data, n (%) 426
Imaging follow-up duration (mo)
 Median [range]; mean ± SD 55.6 [3.15-239]; 65.19 ± 43.02
Imaging outcomes at last follow-up, n (%)
 Stable 215 (51%)
 Regression 178 (42%)
 Progression 33 (8%)
Time to progression (mo)
 Median [range]; mean ± SD 94.07 [11.74-233.34]; 103.74 ± 56.34
Time to regression (mo)
 Median [range]; mean ± SD 64.85 [3.18-191.18]; 70.24 ± 40.87

SD, standard deviation.